Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00866814 · ClinicalTrials.gov registry record
Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch
A clinical trial, sponsored by C. R. Bard.
- Completed
- Registry status
- 119
- Enrollment target
NCT00866814: Completed study, sponsored by C. R. Bard.
NCT00866814 is a clinical trial that has completed, run by C. R. Bard. The registered enrollment target is 119 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00866814 has completed, sponsored by C. R. Bard.
- COMPLETED
- Registry status
- 119 participants
- Enrollment target
Study Summary
This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and complications associated with the device and surgical procedure.
Primary Outcome
A recurrent hernia is a hernia, confirmed by the investigator at any point within the first year after surgery, in the same location as the hernia repaired in the index procedure.
Interventions
- DEVICE Bard Ventrio Hernia Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2009-03 |
| Est. Completion | 2011-05 |
What the finished NCT00866814 record still lists
NCT00866814 is an observational study that tracks outcomes without assigning an intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Bard Ventrio Hernia Patch is the first listed.
NCT00866814 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00866814 about?
NCT00866814 is a clinical study titled "Study Of Hernia Repair Utilizing The Bard Ventrio Hernia Patch". This study will collect data on patients undergoing hernia repair using the Bard Ventrio Hernia Patch. The study will evaluate hernia recurrence rates, operating time, quality of life and complications associated with the device and surgical procedure.
What is the current status of trial NCT00866814?
This trial is currently completed. The enrollment target is 119 participants. The study started on 2009-03. Estimated completion is 2011-05.
What interventions are being tested in trial NCT00866814?
The interventions under investigation include: Bard Ventrio Hernia Patch (DEVICE).
Who is sponsoring clinical trial NCT00866814?
This trial is sponsored by C. R. Bard, which has 75 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04870762 · 119 participants · Phase 2
Customized 3D Printed Oral Stents During Head and Neck Radiotherapy
- NCT05559853 · 119 participants
Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment
- NCT06564389 · 119 participants · Phase 1
FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients
- NCT06742801 · 119 participants · NA
Onyx™ Liquid Embolic IDE Clinical Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia